MIRM
Price
$51.92
Change
-$1.36 (-2.55%)
Updated
Jul 15, 04:59 PM (EDT)
Capitalization
2.57B
15 days until earnings call
OUT
Price
$17.67
Change
-$0.33 (-1.83%)
Updated
Jul 15 closing price
Capitalization
2.79B
15 days until earnings call
Interact to see
Advertisement

MIRM vs OUT

Header iconMIRM vs OUT Comparison
Open Charts MIRM vs OUTBanner chart's image
Mirum Pharmaceuticals
Price$51.92
Change-$1.36 (-2.55%)
Volume$4.5K
Capitalization2.57B
OUTFRONT Media
Price$17.67
Change-$0.33 (-1.83%)
Volume$1.41M
Capitalization2.79B
MIRM vs OUT Comparison Chart in %
Loading...
MIRM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MIRM vs. OUT commentary
Jul 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MIRM is a Hold and OUT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 16, 2025
Stock price -- (MIRM: $51.98 vs. OUT: $17.67)
Brand notoriety: MIRM and OUT are both not notable
MIRM represents the Biotechnology, while OUT is part of the Real Estate Investment Trusts industry
Current volume relative to the 65-day Moving Average: MIRM: 76% vs. OUT: 97%
Market capitalization -- MIRM: $2.57B vs. OUT: $2.79B
MIRM [@Biotechnology] is valued at $2.57B. OUT’s [@Real Estate Investment Trusts] market capitalization is $2.79B. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The market cap for tickers in the [@Real Estate Investment Trusts] industry ranges from $243.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B. The average market capitalization across the [@Real Estate Investment Trusts] industry is $5.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MIRM’s FA Score shows that 1 FA rating(s) are green whileOUT’s FA Score has 0 green FA rating(s).

  • MIRM’s FA Score: 1 green, 4 red.
  • OUT’s FA Score: 0 green, 5 red.
According to our system of comparison, MIRM is a better buy in the long-term than OUT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MIRM’s TA Score shows that 5 TA indicator(s) are bullish while OUT’s TA Score has 4 bullish TA indicator(s).

  • MIRM’s TA Score: 5 bullish, 4 bearish.
  • OUT’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both MIRM and OUT are a good buy in the short-term.

Price Growth

MIRM (@Biotechnology) experienced а +3.40% price change this week, while OUT (@Real Estate Investment Trusts) price change was +5.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.69%. For the same industry, the average monthly price growth was +18.51%, and the average quarterly price growth was +31.06%.

The average weekly price growth across all stocks in the @Real Estate Investment Trusts industry was +0.56%. For the same industry, the average monthly price growth was +2.82%, and the average quarterly price growth was +3.62%.

Reported Earning Dates

MIRM is expected to report earnings on Nov 12, 2025.

OUT is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+2.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Real Estate Investment Trusts (+0.56% weekly)

A real estate investment trust (REIT) is a company any that owns, and in most cases, operates, income-producing real estate – ranging from office and apartment buildings to warehouses, hospitals, shopping centers, hotels and timberlands. Some REITs are involved in financing real estate. Equity REITs invest in and own properties, while mortgage REITs own and invest in property mortgages. REITs are required by law to pay out at least 90% of their annual taxable income (excluding capital gains) to shareholders in the form of dividends. Some REITs could be more cyclical than others; for example, when an economy is undergoing a recession, hotel REITs could be more vulnerable, compared to say healthcare REIT given that healthcare needs are less likely to depend on economic cycles. American Tower Corporation, Prologis, Inc. and Crown Castle International Corp are some of the biggest REIT companies in the U.S.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OUT($2.79B) has a higher market cap than MIRM($2.58B). MIRM YTD gains are higher at: 25.707 vs. OUT (0.737). MIRM has higher annual earnings (EBITDA): -37.56M vs. OUT (-105.7M). MIRM has more cash in the bank: 278M vs. OUT (36M). MIRM has less debt than OUT: MIRM (317M) vs OUT (4.34B). OUT has higher revenues than MIRM: OUT (1.82B) vs MIRM (379M).
MIRMOUTMIRM / OUT
Capitalization2.58B2.79B92%
EBITDA-37.56M-105.7M36%
Gain YTD25.7070.7373,489%
P/E RatioN/A21.03-
Revenue379M1.82B21%
Total Cash278M36M772%
Total Debt317M4.34B7%
FUNDAMENTALS RATINGS
MIRM vs OUT: Fundamental Ratings
MIRM
OUT
OUTLOOK RATING
1..100
7717
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
1570
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4243
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MIRM's Valuation (50) in the null industry is in the same range as OUT (50) in the Real Estate Investment Trusts industry. This means that MIRM’s stock grew similarly to OUT’s over the last 12 months.

MIRM's Profit vs Risk Rating (15) in the null industry is somewhat better than the same rating for OUT (70) in the Real Estate Investment Trusts industry. This means that MIRM’s stock grew somewhat faster than OUT’s over the last 12 months.

MIRM's SMR Rating (100) in the null industry is in the same range as OUT (100) in the Real Estate Investment Trusts industry. This means that MIRM’s stock grew similarly to OUT’s over the last 12 months.

MIRM's Price Growth Rating (42) in the null industry is in the same range as OUT (43) in the Real Estate Investment Trusts industry. This means that MIRM’s stock grew similarly to OUT’s over the last 12 months.

MIRM's P/E Growth Rating (100) in the null industry is in the same range as OUT (100) in the Real Estate Investment Trusts industry. This means that MIRM’s stock grew similarly to OUT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MIRMOUT
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
77%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
75%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
73%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
70%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
68%
Advances
ODDS (%)
Bullish Trend 9 days ago
75%
Bullish Trend 2 days ago
70%
Declines
ODDS (%)
Bearish Trend 5 days ago
68%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
75%
Aroon
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
62%
View a ticker or compare two or three
Interact to see
Advertisement
MIRM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IGFSX16.33N/A
N/A
VY® Morgan Stanley Global Franchise S2
MEERX8.02N/A
N/A
MassMutual International Eq R3
IEDAX11.78N/A
N/A
Voya Large Cap Value A
TAMVX31.74N/A
N/A
T. Rowe Price Mid-Cap Value Adv
TQCRX19.52N/A
N/A
Touchstone Dividend Equity R6

MIRM and

Correlation & Price change

A.I.dvisor indicates that over the last year, MIRM has been loosely correlated with NRIX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if MIRM jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MIRM
1D Price
Change %
MIRM100%
-2.44%
NRIX - MIRM
49%
Loosely correlated
-4.26%
CRNX - MIRM
48%
Loosely correlated
-3.60%
RVMD - MIRM
44%
Loosely correlated
-1.46%
IRON - MIRM
43%
Loosely correlated
-2.55%
KYMR - MIRM
42%
Loosely correlated
+0.02%
More